Our results indicate that S. pneumoniae is the most common bacterial cause of pneumonia in hospitalized patients, and the prevalence of Legionella pneumonia is probably higher in Norway than recognized previously.
To develop a procedure for maximizing the discrimination of smoking status, the authors analysed parallel samples of thiocyanate and cotinine in serum, and carbon monoxide (CO) in expired air in a cohort of 145 male subjects aged 45-65 years. The sensitivity and specificity were 93% and 82%, 97% and 83%, and 98% and 100% for thiocyanate, cotinine, and CO respectively. The results were not significantly improved when combining two or three methods as compared with CO separately. Also, cotinine in urine was analysed in a subgroup of 21 subjects. The correlation coefficient between cotinine in serum and urine was 0.92. In a subgroup of 44 subjects with extensive information on smoking habits, CO was the only indicator significantly related to the quantity of tobacco smoked. We conclude that CO seems sufficient for validating smoking status, but as atypical smokers who are vulnerable to misclassification may be overrepresented in smoking cessation programmes, combining two methods could still be useful. Validating the amount of tobacco smoked is of limited use with the current methods.
ObjectivesTo evaluate survival curves (Kaplan-Meier) as a means of identifying areas in the clinical pathway amenable to quality improvement.DesignObservational before–after study.SettingIn Norway, annual public reporting of nationwide 30-day in-and-out-of-hospital mortality (30D) for three medical conditions started in 2011: first time acute myocardial infarction (AMI), stroke and hip fracture; reported for 2009. 12 of 61 hospitals had statistically significant lower/higher mortality compared with the hospital mean.ParticipantsThree hospitals with significantly higher mortality requested detailed analyses for quality improvement purposes: Telemark Hospital Trust Skien (AMI and stroke), Østfold Hospital Trust Fredrikstad (stroke), Innlandet Hospital Trust Gjøvik (hip fracture).Outcome measuresSurvival curves, crude and risk-adjusted 30D before (2008–2009) and after (2012–2013).InterventionsUnadjusted survival curves for the outlier hospitals were compared to curves based on pooled data from the other hospitals for the 30-day period 2008–2009. For patients admitted with AMI (Skien), stroke (Fredrikstad) and hip fracture (Gjøvik), the curves suggested increased mortality from the initial part of the clinical pathway. For stroke (Skien), increased mortality appeared after about 8 days. The curve profiles were thought to reflect suboptimal care in various phases in the clinical pathway. This informed improvement efforts.ResultsFor 2008–2009, hospital-specific curves differed from other hospitals: borderline significant for AMI (p=0.064), highly significant (p≤0.005) for the remainder. After intervention, no difference was found (p>0.188). Before–after comparison of the curves within each hospital revealed a significant change for Fredrikstad (p=0.006). For the three hospitals, crude 30D declined and they were non-outliers for risk-adjusted 30D for 2013.ConclusionsSurvival curves as a supplement to 30D may be useful for identifying suboptimal care in the clinical pathway, and thus informing design of quality improvement projects.
The purpose of this study was to examine respiratory symptoms and lung function (forced vital capacity [FVC] and forced expiratory volume in 1 second [FEV1]) as related to changes in smoking habits in subjects previously exposed to asbestos. The study was linked to a smoke-ending program among asbestos-exposed males. Subjects were recruited from a population-based survey, and 231 smokers met for the baseline consultation. The baseline prevalences of cough, chronic cough, and dyspnea among smokers were 68.0%, 44.6%, and 42.4%, respectively. Both smoke-ending (n = 10) and tobacco reduction (n = 52) during the 2-year follow-up resulted in remission of cough and chronic cough, whereas dyspnea was unaffected. When the 2-year measurements of FVC and FEV1 were adjusted for the respective baseline measurements, FEV1 tended to improve in subjects who had quit during the study, relative to the continuing smokers. It was concluded that both smoke-ending and reduction of tobacco consumption resulted in reduction of cough and chronic cough, but not of dyspnea. The study further suggests a possible positive effect of smoking cessation on FEV1, but not merely by reduction of tobacco consumption.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.